Investor readiness
Build the company before pitching the company.
Fundraising conversations rarely fail because a founder gave a wrong answer. They fail because a question arrived that the company had not worked through yet. Investor readiness is the work of closing that gap, and almost none of it happens in the deck.
Investor readiness support is part of the Zonvic Founder Network. Membership is currently free for accepted founders.
What investor readiness actually includes
A deck is the output. These are the six things it is an output of, and the ones a serious investor is really evaluating.
A credible development plan
A sequence of work that a scientifically literate investor would recognise as sensible: the cheapest decisive experiment first, timelines that account for the steps founders routinely underestimate, and a named result that would change your mind.
Clear use of proceeds
What the money buys, specifically. Not a pie chart of functions, but the connection between the amount raised and the things that will be known, built, or de-risked by the time it runs out.
Meaningful milestones
Milestones that change what the company is worth, not only what it knows. The test is whether reaching one makes the next financing a stronger conversation than this one.
An appropriate financing strategy
How much, from whom, on what timing, and why this round rather than a different shape. An amount derived from the plan reads very differently from one reverse-engineered out of a runway.
A differentiated investment narrative
A line from mechanism to patient or customer to market that holds together end to end, and that an investor can re-tell accurately to colleagues who were not in the room.
An understanding of risk and diligence
The questions an experienced investor will reach for, anticipated rather than encountered: the competition that is not yet public, the manufacturing step that has no supplier, the assumption the whole thesis rests on.
How the network works on this
Members work on these six areas the way they actually get resolved: in pieces, over months, against a real plan and a real timeline. Feedback is given against The Zonvic Investor Framework, which is published in full, so you can see the reasoning behind a comment and disagree with it where you have better information.
Some of it is best done with someone who has run development programs and also evaluated companies as an investor. Some of it is better done with founders one step ahead of you, who solved the same problem last year. The network is built to give you both.
A starting point
Start with an investor readiness assessment.
It helps to know where you stand before deciding what to work on. The Complimentary Assessment applies The Zonvic Investor Framework to your own materials and returns the strengths worth leading with, the investor questions to expect, and the areas most worth preparing before outreach.
Treat it as a first read and a place to start a conversation, not a verdict. It produces an indicative readiness score, and that number is the least interesting part of the output: it is useful for noticing movement over time, and it is not a measurement of whether your company deserves funding. The findings and the priorities are what to work from.
Optional one-on-one advisory support
Selected founders may also engage Zonvic for additional one-on-one advisory support. Some companies want a focused working session on a specific raise; a few, usually those actively fundraising, want an experienced person alongside them through the whole process.
Both are paid engagements, both are optional, and neither is a condition of joining the network or of anything membership includes. Zonvic does not invest in the companies it advises, does not make investor introductions for a fee, and takes no success fee on a raise.
Work on the company, not just the pitch.
Apply to join a network of life science founders preparing for financing with a clearer view of what investors are actually evaluating.
Membership is currently free for accepted founders.
Zonvic does not raise capital on your behalf and does not guarantee any fundraising outcome.